aRCC: 1L Treatment Options and Patient Management


GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After Multiple Lines of Systemic Therapy

205 views
December 28, 2022
Comments 1
Login to view comments. Click here to Login